FOPRYZE Trademark

Trademark Overview


On Thursday, October 3, 2024, a trademark application was filed for FOPRYZE with the United States Patent and Trademark Office. The USPTO has given the FOPRYZE trademark a serial number of 98784459. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 1, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The FOPRYZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders
fopryze

General Information


Serial Number98784459
Word MarkFOPRYZE
Filing DateThursday, October 3, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Thursday, October 3, 2024NEW APPLICATION ENTERED
Friday, October 18, 2024ASSIGNED TO EXAMINER
Thursday, October 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 25, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 1, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 1, 2025SOU EXTENSION 1 GRANTED
Wednesday, July 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 1, 2025SOU EXTENSION 1 FILED